melengestrol acetate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| steroids, progestogens | 5576 | 2919-66-6 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D005938 | Glucocorticoids |
| MeSH PA | D006728 | Hormones |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Cattle | To increase rate of weight gain | Indication |
| Cattle | To improve feed efficiency | Indication |
| Cattle | Estrus supression | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| MGA 100, MGA 200 | Zoetis Inc. | 1 |
| MGA 100, MGA 200, MGA 500 | Zoetis Inc. | 1 |
| MGA (liquid) and TM | Zoetis Inc. | 2 |
| MGA and TM | Zoetis Inc. | 2 |
| MGA 100-200 / Rumensin, MGA 100-200 Premix / Rumensin | Zoetis Inc. | 2 |
| MGA 500 plus Rumensin | Zoetis Inc. | 2 |
| MGA and Rumensin and Tylan | Zoetis Inc. | 3 |
| MGA and Bovatec and Tylan | Zoetis Inc. | 3 |
| MGA and Tylan | Zoetis Inc. | 2 |
| MGA and Tylan | Zoetis Inc. | 2 |
| Bovatec / MGA 100, Bovatec / MGA 200 | Zoetis Inc. | 2 |
| Bovatec / MGA 500 | Zoetis Inc. | 2 |
| Optaflexx and Rumensin and Tylanand MGA | Elanco US Inc. | 4 |
| Optaflexx / Rumensin / MGA | Elanco US Inc. | 3 |
| Zilmax and Rumensin and Tylan and MGA | Intervet Inc. | 4 |
| Zilmax/Rumensin/MGA | Intervet Inc. | 3 |
| Zilmax plus MGA | Intervet Inc. | 2 |
| MGA and Aureomycin | Zoetis Inc. | 2 |
| MGA and Bovatec and Aureomycin | Zoetis Inc. | 3 |
| Heifermax 500 | Elanco US Inc. | 1 |
| HeifermaX 500 / Rumensin / Tylan | Elanco US Inc. | 3 |
| CycleGuard 500 | Huvepharma EOOD | 1 |
| Heifermax 500 Liquid Premix and Rumensin | Elanco US Inc. | 2 |
| Heifermax / Optaflexx / Rumensin / Tylan | Elanco US Inc. | 4 |
| Heifermax 500 Liquid Premix and Tylan | Elanco US Inc. | 2 |
| HeifermaX 500 plus Bovatec and Tylan | Elanco US Inc. | 3 |
| Heifermax 500/Optaflexx/Rumensin | Elanco US Inc. | 3 |
| HeifermaX 500 plus Bovatec | Elanco US Inc. | 2 |
| Heifermax 500/Zilmax/Rumensin | Elanco US Inc. | 3 |
| Heifermax 500/Zilmax/Rumensin/Tylan | Elanco US Inc. | 4 |
| Heifermax 500 plus Zilmax | Elanco US Inc. | 2 |
| MGA plus Tylovet 100 | Huvepharma EOOD | 2 |
| MGA, Rumensin and Tylovet 100 | Huvepharma EOOD | 3 |
| MGA/ Bovatec/ Tylovet 100 | Huvepharma EOOD | 3 |
| Zilmax/Rumensin/Tylovet 100/MGA | Huvepharma EOOD | 4 |
| Actogain 45/Rumensin/MGA | Zoetis Inc. | 3 |
| Actogain 45/Rumensin/Tylan/MGA | Zoetis Inc. | 4 |
| Optaflexx 45/Rumensin/Tylovet 100/MGA | Huvepharma EOOD | 4 |
| Actogain 45/Rumensin/Tylovet 100/MGA | Zoetis Inc. | 4 |
| Optaflexx and Monovet and Tylovet and MGA | Huvepharma EOOD | 4 |
| Actogain and Monovet and Tylovet and MGA | Huvepharma EOOD | 4 |
| Optaflexx and Monovet and Tylan and MGA | Huvepharma EOOD | 4 |
| Actogain and Monovet and Tylan and MGA | Huvepharma EOOD | 4 |
| MGA and Monovet | Huvepharma EOOD | 2 |
| Actogain and Monovet and MGA | Huvepharma EOOD | 3 |
| MGA and Monovet and Tylovet | Huvepharma EOOD | 3 |
| MGA and Monovet and Tylan | Huvepharma EOOD | 3 |
| Optigrid and Monovet and MGA | Huvepharma EOOD | 3 |
| Optigrid and Monovet and Tylovet and MGA | Huvepharma EOOD | 4 |
| Optigrid and Monovet and CycleGuard | Huvepharma EOOD | 3 |
| CycleGuard and Monovet and Tylovet | Huvepharma EOOD | 3 |
| Optigrid and Monovet and Tylovet and CycleGuard | Huvepharma EOOD | 4 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| CHEBI:34831 | CHEBI |
| CHEMBL1328968 | ChEMBL_ID |
| DB14659 | DRUGBANK_ID |
| DB11529 | DRUGBANK_ID |
| D008552 | MESH_DESCRIPTOR_UI |
| C0025223 | UMLSCUI |
| C0376337 | UMLSCUI |
| 126116004 | SNOMEDCT_US |
| 126117008 | SNOMEDCT_US |
| 96360004 | SNOMEDCT_US |
| 1528 | INN_ID |
| 5633-18-1 | SECONDARY_CAS_RN |
| D04900 | KEGG_DRUG |
| 250948 | PUBCHEM_CID |
| 9906614 | PUBCHEM_CID |
| 1537798 | RXNORM |
| 4W5HDS3936 | UNII |
| BX98J4T6JU | UNII |
Pharmaceutical products:
None